Adicet Bio (ACET) Interest Coverage Ratio Growth (3y) (2020 - 2026)
Adicet Bio (ACET) Interest Coverage Ratio Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 29.79% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 33.30% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 78.77% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 81.16% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -35.50% |
| 10 | Adicet Bio | 98.21 Mn | -19.98 Mn | - | 51.20% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 17.91% |
| Mar 31, 2026 | 19.63% |
| Dec 31, 2025 | -445.00% |
| Sep 30, 2025 | -142.31% |
| Jun 30, 2025 | -2.50% |
| Mar 31, 2025 | -296.60% |
| Dec 31, 2024 | 76.87% |
| Sep 30, 2024 | 7.44% |
| Jun 30, 2024 | -53.36% |
| Mar 31, 2024 | 18.91% |
| Sep 30, 2023 | -105.17% |
| Jun 30, 2023 | 70.81% |
| Mar 31, 2023 | 80.27% |
| Dec 31, 2022 | 61.80% |
| Sep 30, 2022 | 46.94% |
| Jun 30, 2022 | 35.14% |
| Mar 31, 2022 | 26.16% |
| Dec 31, 2021 | -519.82% |
| Sep 30, 2021 | 6.42% |
| Jun 30, 2021 | 46.89% |